Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor

Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor

The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the Coronavirus Disease 2019 (COVID-19) has spread through the globe at an alarming speed. The disease has become a global pandemic affecting millions of people and created public health crises worldwi...

Full description

Bibliographic Details
Main Authors: Christopher Ton, Victoria Stabile, Elizabeth Carey, Adam Maraikar, Travis Whitmer, Samantha Marrone, Nelson Lee Afanador, Igor Zabrodin, Greeshma Manomohan, Melissa Whiteman, Carl Hofmann
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Biotechnology Reports
Subjects:
VSV∆G-SARS-CoV-2
Closed process
Vero cells
Serum-free
Microcarriers
Single use bioreactor
Online Access:http://www.sciencedirect.com/science/article/pii/S2215017X23000024

Internet

http://www.sciencedirect.com/science/article/pii/S2215017X23000024

Similar Items